Skip to main content
Clinical Trials/NCT07057869
NCT07057869CompletedNot Applicable

Comparison of the Effects of Different Ultrasound Treatment Durations on Pain and Physical Function in Patients With Knee Osteoarthritis

KTO Karatay University1 site in 1 country60 target enrollmentStarted: May 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Physical Function (WOMAC)

Study Overview

Brief Summary

This study aims to compare the effects of different ultrasound treatment durations on pain and physical function in patients with knee osteoarthritis. Sixty sedentary volunteers aged 18-85 with diagnosed knee osteoarthritis will be randomly assigned to three groups receiving ultrasound therapy for 5, 10, or 15 minutes, respectively, alongside conventional treatment. Pain and physical function will be assessed using the Visual Analog Scale (VAS), WOMAC Osteoarthritis Index, and 2-minute walk test at baseline and after 4 weeks of treatment. The results will help determine the optimal ultrasound treatment duration for improving symptoms in knee osteoarthritis patients.

Detailed Description

This clinical trial investigates the effects of different ultrasound therapy durations on pain relief and physical function improvement in patients with knee osteoarthritis. Sixty sedentary individuals aged 18 to 85 years diagnosed with knee osteoarthritis will be enrolled and randomly assigned to three groups receiving ultrasound treatment for 5, 10, or 15 minutes, respectively, alongside conventional therapy (such as hot packs, TENS, etc.).

Ultrasound therapy will be applied by a qualified physiotherapist at 1 W/cm² intensity and 1 MHz frequency in pulsed mode, for four weeks. Evaluations will be conducted at baseline and after treatment completion, using the Visual Analog Scale (VAS) for pain assessment, WOMAC Osteoarthritis Index for physical function, and a 2-minute walk test to measure walking performance.

This study aims to provide scientific evidence on the optimal ultrasound treatment duration for knee osteoarthritis, contributing to improved rehabilitation protocols. The findings will be prepared for publication in an international peer-reviewed journal.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

This study is an open-label trial where both patients and treating physiotherapists are aware of the ultrasound treatment duration. Outcome assessors are blinded to group assignments to reduce assessment bias.

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Individuals aged between 18 and 85 years Diagnosed with knee osteoarthritis Recommended for ultrasound therapy as part of routine physical therapy Willing to participate voluntarily and provide written informed consent

Exclusion Criteria

  • •History of acute knee trauma Individuals with contraindications to ultrasound therapy

Arms & Interventions

5-minute Ultrasound Group

Experimental

Patients receive 5 minutes of pulsed ultrasound therapy (1 W/cm², 1 MHz) alongside conventional treatment for 4 weeks.

Intervention: 5-minute Ultrasound Group (Procedure)

10-minute Ultrasound Group

Experimental

Patients receive 10 minutes of pulsed ultrasound therapy (1 W/cm², 1 MHz) alongside conventional treatment for 4 weeks.

Intervention: 10-minute Ultrasound Group (Procedure)

15-minute Ultrasound Group

Experimental

Patients receive 15 minutes of pulsed ultrasound therapy (1 W/cm², 1 MHz) alongside conventional treatment for 4 weeks.

Intervention: 15-minute Ultrasound Group (Procedure)

Outcomes

Primary Outcomes

Physical Function (WOMAC)

Time Frame: Baseline, 4 weeks

Evaluation of physical function and stiffness using the WOMAC index at baseline and after 4 weeks of treatment.

Pain Intensity (VAS)

Time Frame: Baseline, 4 weeks

Assessment of knee pain intensity using the Visual Analog Scale (VAS) at baseline and after 4 weeks of treatment.

Secondary Outcomes

  • Walking Distance (2-Min Walk)(Baseline, 4 weeks)

Investigators

Sponsor
KTO Karatay University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mustafa Savaş Torlak

Associate Professor

KTO Karatay University

Study Sites (1)

Loading locations...

Similar Trials